274 related articles for article (PubMed ID: 25758852)
1. Functionalization of fluorinated benzenesulfonamides and their inhibitory properties toward carbonic anhydrases.
Dudutienė V; Zubrienė A; Smirnov A; Timm DD; Smirnovienė J; Kazokaitė J; Michailovienė V; Zakšauskas A; Manakova E; Gražulis S; Matulis D
ChemMedChem; 2015 Apr; 10(4):662-87. PubMed ID: 25758852
[TBL] [Abstract][Full Text] [Related]
2. 4-Substituted-2,3,5,6-tetrafluorobenzenesulfonamides as inhibitors of carbonic anhydrases I, II, VII, XII, and XIII.
Dudutienė V; Zubrienė A; Smirnov A; Gylytė J; Timm D; Manakova E; Gražulis S; Matulis D
Bioorg Med Chem; 2013 Apr; 21(7):2093-106. PubMed ID: 23394791
[TBL] [Abstract][Full Text] [Related]
3. Benzenesulfonamides with pyrimidine moiety as inhibitors of human carbonic anhydrases I, II, VI, VII, XII, and XIII.
Čapkauskaitė E; Zubrienė A; Smirnov A; Torresan J; Kišonaitė M; Kazokaitė J; Gylytė J; Michailovienė V; Jogaitė V; Manakova E; Gražulis S; Tumkevičius S; Matulis D
Bioorg Med Chem; 2013 Nov; 21(22):6937-47. PubMed ID: 24103428
[TBL] [Abstract][Full Text] [Related]
4. Design of [(2-pyrimidinylthio)acetyl]benzenesulfonamides as inhibitors of human carbonic anhydrases.
Čapkauskaitė E; Zubrienė A; Baranauskienė L; Tamulaitienė G; Manakova E; Kairys V; Gražulis S; Tumkevičius S; Matulis D
Eur J Med Chem; 2012 May; 51():259-70. PubMed ID: 22440859
[TBL] [Abstract][Full Text] [Related]
5. 4-[N-(substituted 4-pyrimidinyl)amino]benzenesulfonamides as inhibitors of carbonic anhydrase isozymes I, II, VII, and XIII.
Sūdžius J; Baranauskienė L; Golovenko D; Matulienė J; Michailovienė V; Torresan J; Jachno J; Sukackaitė R; Manakova E; Gražulis S; Tumkevičius S; Matulis D
Bioorg Med Chem; 2010 Nov; 18(21):7413-21. PubMed ID: 20889345
[TBL] [Abstract][Full Text] [Related]
6. Intrinsic Thermodynamics and Structures of 2,4- and 3,4-Substituted Fluorinated Benzenesulfonamides Binding to Carbonic Anhydrases.
Zubrienė A; Smirnov A; Dudutienė V; Timm DD; Matulienė J; Michailovienė V; Zakšauskas A; Manakova E; Gražulis S; Matulis D
ChemMedChem; 2017 Jan; 12(2):161-176. PubMed ID: 28001003
[TBL] [Abstract][Full Text] [Related]
7. Indapamide-like benzenesulfonamides as inhibitors of carbonic anhydrases I, II, VII, and XIII.
Čapkauskaitė E; Baranauskienė L; Golovenko D; Manakova E; Gražulis S; Tumkevičius S; Matulis D
Bioorg Med Chem; 2010 Nov; 18(21):7357-64. PubMed ID: 20926301
[TBL] [Abstract][Full Text] [Related]
8. Benzenesulfonamides with benzimidazole moieties as inhibitors of carbonic anhydrases I, II, VII, XII and XIII.
Zubrienė A; Čapkauskaitė E; Gylytė J; Kišonaitė M; Tumkevičius S; Matulis D
J Enzyme Inhib Med Chem; 2014 Feb; 29(1):124-31. PubMed ID: 23356363
[TBL] [Abstract][Full Text] [Related]
9. Thiazole-substituted benzenesulfonamides as inhibitors of 12 human carbonic anhydrases.
Čapkauskaitė E; Zubrienė A; Paketurytė V; Timm DD; Tumkevičius S; Matulis D
Bioorg Chem; 2018 Apr; 77():534-541. PubMed ID: 29459130
[TBL] [Abstract][Full Text] [Related]
10. Design of two-tail compounds with rotationally fixed benzenesulfonamide ring as inhibitors of carbonic anhydrases.
Zakšauskas A; Čapkauskaitė E; Jezepčikas L; Linkuvienė V; Kišonaitė M; Smirnov A; Manakova E; Gražulis S; Matulis D
Eur J Med Chem; 2018 Aug; 156():61-78. PubMed ID: 30006175
[TBL] [Abstract][Full Text] [Related]
11. Sulfonamides incorporating 1,3,5-triazine moieties selectively and potently inhibit carbonic anhydrase transmembrane isoforms IX, XII and XIV over cytosolic isoforms I and II: Solution and X-ray crystallographic studies.
Carta F; Garaj V; Maresca A; Wagner J; Avvaru BS; Robbins AH; Scozzafava A; McKenna R; Supuran CT
Bioorg Med Chem; 2011 May; 19(10):3105-19. PubMed ID: 21515057
[TBL] [Abstract][Full Text] [Related]
12. Thermodynamic, kinetic, and structural parameterization of human carbonic anhydrase interactions toward enhanced inhibitor design.
Linkuvienė V; Zubrienė A; Manakova E; Petrauskas V; Baranauskienė L; Zakšauskas A; Smirnov A; Gražulis S; Ladbury JE; Matulis D
Q Rev Biophys; 2018 Jan; 51():e10. PubMed ID: 30912486
[TBL] [Abstract][Full Text] [Related]
13. Saccharin sulfonamides as inhibitors of carbonic anhydrases I, II, VII, XII, and XIII.
Morkūnaitė V; Baranauskienė L; Zubrienė A; Kairys V; Ivanova J; Trapencieris P; Matulis D
Biomed Res Int; 2014; 2014():638902. PubMed ID: 25276805
[TBL] [Abstract][Full Text] [Related]
14. Halogenated and di-substituted benzenesulfonamides as selective inhibitors of carbonic anhydrase isoforms.
Zakšauskas A; Čapkauskaitė E; Jezepčikas L; Linkuvienė V; Paketurytė V; Smirnov A; Leitans J; Kazaks A; Dvinskis E; Manakova E; Gražulis S; Tars K; Matulis D
Eur J Med Chem; 2020 Jan; 185():111825. PubMed ID: 31740053
[TBL] [Abstract][Full Text] [Related]
15. Pyrrolidinone-bearing methylated and halogenated benzenesulfonamides as inhibitors of carbonic anhydrases.
Vaškevičienė I; Paketurytė V; Pajanok N; Žukauskas Š; Sapijanskaitė B; Kantminienė K; Mickevičius V; Zubrienė A; Matulis D
Bioorg Med Chem; 2019 Jan; 27(2):322-337. PubMed ID: 30553625
[TBL] [Abstract][Full Text] [Related]
16. Carbonic anhydrase inhibitors: inhibition of human cytosolic isozymes I and II and tumor-associated isozymes IX and XII with S-substituted 4-chloro-2-mercapto-5-methyl-benzenesulfonamides.
Saczewski F; Innocenti A; Sławiński J; Kornicka A; Brzozowski Z; Pomarnacka E; Scozzafava A; Temperini C; Supuran CT
Bioorg Med Chem; 2008 Apr; 16(7):3933-40. PubMed ID: 18242998
[TBL] [Abstract][Full Text] [Related]
17. Discovery and characterization of novel selective inhibitors of carbonic anhydrase IX.
Dudutienė V; Matulienė J; Smirnov A; Timm DD; Zubrienė A; Baranauskienė L; Morkūnaite V; Smirnovienė J; Michailovienė V; Juozapaitienė V; Mickevičiūtė A; Kazokaitė J; Bakšytė S; Kasiliauskaitė A; Jachno J; Revuckienė J; Kišonaitė M; Pilipuitytė V; Ivanauskaitė E; Milinavičiūtė G; Smirnovas V; Petrikaitė V; Kairys V; Petrauskas V; Norvaišas P; Lingė D; Gibieža P; Capkauskaitė E; Zakšauskas A; Kazlauskas E; Manakova E; Gražulis S; Ladbury JE; Matulis D
J Med Chem; 2014 Nov; 57(22):9435-46. PubMed ID: 25358084
[TBL] [Abstract][Full Text] [Related]
18. Benzimidazole design, synthesis, and docking to build selective carbonic anhydrase VA inhibitors.
Čapkauskaitė E; Zakšauskas A; Ruibys V; Linkuvienė V; Paketurytė V; Gedgaudas M; Kairys V; Matulis D
Bioorg Med Chem; 2018 Feb; 26(3):675-687. PubMed ID: 29305297
[TBL] [Abstract][Full Text] [Related]
19. Conformational variability of different sulfonamide inhibitors with thienyl-acetamido moieties attributes to differential binding in the active site of cytosolic human carbonic anhydrase isoforms.
Biswas S; Aggarwal M; Güzel Ö; Scozzafava A; McKenna R; Supuran CT
Bioorg Med Chem; 2011 Jun; 19(12):3732-8. PubMed ID: 21620713
[TBL] [Abstract][Full Text] [Related]
20. Discovery of novel isatin-based sulfonamides with potent and selective inhibition of the tumor-associated carbonic anhydrase isoforms IX and XII.
Güzel-Akdemir Ö; Akdemir A; Karalı N; Supuran CT
Org Biomol Chem; 2015 Jun; 13(23):6493-9. PubMed ID: 25967275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
